Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06460064
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2024-04-29
Brief Title:
First-in-human Study to Assess the Safety Tolerability and Immunogenicity of the Adjuvanted Universal Influenza Vaccine fH1DSP-0546LP
Sponsor:
Sumitomo Pharma Co Ltd
Organization:
Sumitomo Pharma Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-26
Start Date Type:
ACTUAL
Primary Completion Date:
2026-03-27
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03-27
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-29
First Submit QC Date:
June 10 2024
Study First Post Date:
2024-06-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-11
Last Update Post Date:
2024-07-15
Last Update Post Date Type:
ESTIMATED